Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- befree-2016 importedOn "2016-02-19" NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_assertion wasGeneratedBy ECO_0000203 NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_assertion wasDerivedFrom befree-2016 NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_assertion SIO_000772 17688376 NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_assertion evidence source_evidence_literature NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.
- NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_assertion description "[55 patients with locally advanced rectal carcinoma (cT3-4, N0, M0 or cT2-4,N+, M0) were treated with capecitabine 825 mg/m2 twice a day and pelvic radiotherapy 1,8 Gy daily up to cumulative dose of 45 Gy, boosting up to 50,4 Gy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP624248.RAX7yB_DJfXP5nQncshXPRk40KFmNqm0C-p9am7K3afGQ130_provenance.